Asim Afaq, M.D.

Harold C. Simmons Comprehensive Cancer Center

Radiology - General

New Patient Appointment or 214-645-9729

Education & Training

Medical School - Imperial College London, University of London, School of Medicine (1996-2002)
Fellowship - Memorial Sloan Kettering Cancer Center (2010-2012), Molecular Imaging
Residency - Imperial College Healthcare, NHS Trust (2005-2010), Radiology
Other Post Graduate Training - University College of London (2019)
Internship - University of London (2002-2005), Internal Medicine & General Surgery
Fellowship - Royal Marsden Hospital (2009-2010), Radiology

Books & Publications

Publications
- Clinical Implementation of PSMA-PET Guided Tumor Response-Based Boost Adaptation in Online Adaptive Radiotherapy for High-Risk Prostate Cancer
  Li R, Lin M, Nguyen NC, Su FC, Parsons DD, Salcedo E, Phillips E, Domal S, Garant A, Hannan R, Yang DX, Afaq A, Lee M, Oz OK, Desai NB Cancers 2025 Sep 17
- Current Applications of PET/MR: Part II: Clinical Applications II
  Kohan A, Hanneman K, Mirshahvalad SA, Afaq A, Mallak N, Metser U, Veit-Haibach P Canadian Association of Radiologists Journal 2024 Nov 75 826-837
- Deep learning applications for quantitative and qualitative PET in PET/MR: technical and clinical unmet needs
  Yang J, Afaq A, Sibley R, McMilan A, Pirasteh A Magnetic Resonance Materials in Physics, Biology and Medicine 2024 Aug 37 749-763
- ⁶⁸Ga-PSMA-Avid Intranasal Solitary Fibrous Tumor
  Riaz S, Priftakis D, Afaq A, Kayani I, Bomanji J Clinical nuclear medicine 2023 Apr 48 E184-E185
- The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer
  Wang Y, Galante JR, Haroon A, Wan S, Afaq A, Payne H, Bomanji J, Adeleke S, Kasivisvanathan V Nature Reviews Urology 2022 Aug 19 475-493
- Impact of ¹⁸F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical prostatectomy
  Author Collaboration F, Payne H, Bomanji J, Bottomley D, Scarsbrook AF, Teoh EJ, Gleeson FV, Bradley KM, Andrade G, Camilieri P, Hyde K, Macpherson R, Patel N, Sabharwal A, Subesinghe M, Chau A, Miller MP, Afaq A, van As N, Chua S, Hoskin P, Chambers A, Cook GJ, Warbey VS, Han S, Leung HY Nuclear Medicine Communications 2022 Feb 43 201-211
- Correction to: FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis (European Journal of Nuclear Medicine and Molecular Imaging, (2021), 49, 1, (371-384), 10.1007/s00259-021-05318-y)
  Chen SH, Miles K, Taylor SA, Ganeshan B, Rodriquez M, Fraioli F, Wan S, Afaq A, Shortman R, Walls D, Hoy L, Endozo R, Bhargava A, Hanson M, Huang J, Raouf S, Francis D, Siddiqi S, Arulampalam T, Sizer B, Machesney M, Reay-Jones N, Dindyal S, Ng T, Groves AM European Journal of Nuclear Medicine and Molecular Imaging 2022 Jan 49 786-787
- A Phase II, Open-Label Study to Assess Safety and Management Change Using ⁶⁸Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study
  Afaq A, Payne H, Davda R, Hines J, Cook GJ, Meagher M, Priftakis D, Warbey VS, Kelkar A, Orczyk C, Mitra A, Needleman S, Ferris M, Mullen G, Bomanji J Journal of Nuclear Medicine 2021 Dec 62 1727-1734
- FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis
  Chen Sh, Miles K, Taylor SA, Ganeshan B, Rodriquez M, Fraioli F, Wan S, Afaq A, Shortman R, Walls D, Hoy L, Endozo R, Bhargava A, Hanson M, Huang J, Raouf S, Francis D, Siddiqi S, Arulampalam T, Sizer B, Machesney M, Reay-Jones N, Dindyal S, Ng T, Groves AM European Journal of Nuclear Medicine and Molecular Imaging 2021 Dec 49 371-384
- Pitfalls on PET/MRI
  Afaq A, Faul D, Chebrolu VV, Wan S, Hope TA, Haibach PV, Bomanji J Seminars in Nuclear Medicine 2021 Sep 51 529-539
- Texture analysis of fractional water content images acquired during pet/mri: Initial evidence for an association with total lesion glycolysis, survival and gene mutation profile in primary colorectal cancer
  Ganeshan B, Miles K, Afaq A, Punwani S, Rodriguez M, Wan S, Walls D, Hoy L, Khan S, Endozo R, Shortman R, Hoath J, Bhargava A, Hanson M, Francis D, Arulampalam T, Dindyal S, Chen SH, Ng T, Groves A Cancers 2021 Jun 13
- Effect of ¹⁸F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial
  Author Collaboration Fs, Scarsbrook AF, Bottomley D, Teoh EJ, Bradley KM, Payne H, Afaq A, Bomanji J, van As N, Chua S, Hoskin P, Chambers A, Cook GJ, Warbey VS, Han S, Leung HY, Chau A, Miller MP, Gleeson FV, Andrade G, Camilieri P, Hyde K, Macpherson R, Patel N, Sabharwal A, Subesinghe M, Tsakok M International Journal of Radiation Oncology Biology Physics 2020 Jun 107 316-324
- Imaging of Prostate Cancer Recurrence in the Vas Deferens with ⁶⁸Ga-PSMA PET/CT
  Priftakis D, Afaq A, Bomanji J Clinical nuclear medicine 2020 Jan 45 49-51
- Is it time to fund routine NHS usage of PSMA PET-CT?
  Afaq A, Ell PJ, Bomanji JB Nuclear Medicine Communications 2019 Oct 40 975-979
- Correction to: The clinical utility of prostate cancer heterogeneity using texture analysis of multiparametric MRI (International Urology and Nephrology, (2019), 51, 5, (817-824), 10.1007/s11255-019-02134-0)
  Hameed M, Ganeshan B, Shur J, Mukherjee S, Afaq A, Hellawell G, Batura D International Urology and Nephrology 2019 Jul 51 1171
- UK guidelines on ¹⁸F-fluciclovine PET/CT in prostate cancer imaging
  Afaq A, Gleeson F, Scarsbrook A, Bradley K, Subesinghe M, MacPherson R, Haroon A, Patel N, Chua S, Wong WL, Vinjamuri S, Warbey VS, Cook GJ, Bomanji J Nuclear Medicine Communications 2019 Jul 40 662-674
- The clinical utility of prostate cancer heterogeneity using texture analysis of multiparametric MRI
  Hameed M, Ganeshan B, Shur J, Mukherjee S, Afaq A, Batura D International Urology and Nephrology 2019 May 51 817-824
- Magnetic resonance texture analysis in identifying complete pathological response to neoadjuvant treatment in locally advanced rectal cancer
  Aker M, Ganeshan B, Afaq A, Wan S, Groves AM, Arulampalam T Diseases of the Colon and Rectum 2019 Feb 62 163-170
- ⁶⁸ Ga-Prostate-Specific Membrane Antigen PET/CT: Incidental Finding of a Liposarcoma
  Militano V, Afaq A, Bomanji J Clinical nuclear medicine 2019 Feb 44 e90-e92
- Challenges in glucoCEST MR body imaging at 3 Tesla
  Kim M, Torrealdea F, Adeleke S, Rega M, Evans V, Beeston T, Soteriou K, Thust S, Kujawa A, Okuchi S, Isaac E, Piga W, Lambert JR, Afaq A, Demetriou E, Choudhary P, Cheung KK, Naik S, Atkinson D, Punwani S, Golay X Quantitative Imaging in Medicine and Surgery 2019 9 1628-1640
- Prostate-specific membrane antigen positron emission tomography in the management of recurrent prostate cancer
  Afaq A, Bomanji J British Medical Bulletin 2018 Dec 128 37-48
- Phenotypic appearances of prostate utilizing PET-MRI and PET-CT with 68 Ga-PSMA, radiolabelled choline and 68 Ga-DOTATATE
  Haroon A, Afaq A, Nuthakki S, Freeman A, Biassoni L, Fanti S, Beheshti M, Jan H, Vinjamuri S, Emberton M, Bomanji J Nuclear Medicine Communications 2018 39 196-204
- Impact of ⁶⁸ Ga-prostate-specific membrane antigen PET/CT on prostate cancer management
  Afaq A, Alahmed S, Chen SH, Lengana T, Haroon A, Payne H, Ahmed H, Punwani S, Sathekge M, Bomanji J Journal of Nuclear Medicine 2018 Jan 59 89-92
- New frontiers in prostate cancer imaging: clinical utility of prostate-specific membrane antigen positron emission tomography
  Afaq A, Batura D, Bomanji J International Urology and Nephrology 2017 May 49 803-810
- Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy
  Jalil O, Afaq A, Ganeshan B, Patel UB, Boone D, Endozo R, Groves A, Sizer B, Arulampalam T Colorectal Disease 2017 Apr 19 349-362
- CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin’s and aggressive non-hodgkin’s lymphomas
  Ganeshan B, Miles KA, Babikir S, Shortman R, Afaq A, Ardeshna KM, Groves AM, Kayani I European Radiology 2017 Mar 27 1012-1020
- Comparison of PET/MRI with PET/CT in the Evaluation of Disease Status in Lymphoma
  Afaq A, Fraioli F, Sidhu H, Wan S, Punwani S, Chen SH, Akin O, Linch D, Ardeshna K, Lambert J, Miles K, Groves A, Kayani I Clinical nuclear medicine 2017 Jan 42 e1-e7
- Volume and landmark analysis: Comparison of MRI measurements obtained with an endorectal coil and with a phased-array coil
  Mazaheri Y, Afaq AA, Jung SI, Goldman DA, Wang L, Aslan H, Zelefsky MJ, Akin O, Hricak H Clinical Radiology 2015 Apr 70 379-386
- PET/MRI in the upper abdomen
  Gavra M, Syed R, Fraioli F, Afaq A, Bomanji J Seminars in Nuclear Medicine 2015 45 282-292
- Assessing therapy response of secreting pineal germ cell tumor on simultaneous ¹⁸F-choline PET/MRI
  Panagiotidis E, Shankar A, Afaq A, Bomanji J Clinical nuclear medicine 2014 Sep 39 e387-e388
- Prostate MRI: Evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score
  Donati OF, Afaq A, Vargas HA, Mazaheri Y, Zheng J, Moskowitz CS, Hricak H, Akin O Clinical Cancer Research 2014 Jul 20 3705-3711
- Ultrasound of the gall bladder and biliary tree: Part 2
  Wills M, Harvey CJ, Kuzmich S, Afaq A, Cosgrove D British Journal of Hospital Medicine 2014 Jun 75 318-324
- Ultrasound of the gall bladder and biliary tree: Part 1
  Wills M, Harvey CJ, Kuzmich S, Afaq A, Cosgrove D British Journal of Hospital Medicine 2014 Jun 75 312-317
- Use of PET/MRI for identification and characterisation of liver lesions
  Nasoodi A, Syed R, Afaq A, Bomanji J Clinical and Translational Imaging 2014 Apr 2 129-137
- Prostate cancer aggressiveness: Assessment with whole-lesion histogram analysis of the apparent diffusion coefficient
  Donati OF, Mazaheri Y, Afaq A, Vargas HA, Zheng J, Moskowitz CS, Hricak H, Akin O RADIOLOGY 2014 Apr 271 143-152
- Characterizing malignant liver lesions with contrast-enhanced ultrasound
  Wills M, Harvey CJ, Kuzmich S, Afaq A, Lim A, Cosgrove D British Journal of Hospital Medicine 2014 Mar 75 151-154
- Characterizing benign liver lesions and trauma with contrast-enhanced ultrasound
  Wills M, Harvey CJ, Kuzmich S, Afaq A, Lim A, Cosgrove D British Journal of Hospital Medicine 2014 Feb 75 91-95
- Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients
  Win T, Thomas BA, Lambrou T, Hutton BF, Screaton NJ, Porter JC, Maher TM, Endozo R, Shortman RI, Afaq A, Lukey P, Ell PJ, Groves AM European Journal of Nuclear Medicine and Molecular Imaging 2014 41 337-342
- PET/CT in breast cancer
  Afaq A, Sharma B 2014 Jan 142-164
- Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice
  Al-Nabhani KZ, Syed R, Michopoulou S, Alkalbani J, Afaq A, Panagiotidis E, O'Meara C, Groves A, Ell P, Bomanji J Journal of Nuclear Medicine 2014 Jan 55 88-94
- PET/MRI: A new technology in the field of molecular imaging
  Afaq A, Syed R, Bomanji J British Medical Bulletin 2013 Dec 108 159-171
- Pretreatment endorectal coil magnetic resonance imaging findings predict biochemical tumor control in prostate cancer patients treated with combination brachytherapy and external-beam radiotherapy
  Riaz N, Afaq A, Akin O, Pei X, Kollmeier MA, Cox B, Hricak H, Zelefsky MJ International Journal of Radiation Oncology Biology Physics 2012 Nov 84 707-711
- Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer
  Vargas HA, Akin O, Afaq A, Goldman D, Zheng J, Moskowitz CS, Shukla-Dave A, Eastham J, Scardino P, Hricak H Journal of Urology 2012 Nov 188 1732-1738
- Diffusion-weighted magnetic resonance imaging of the prostate: Improved robustness with stretched exponential modeling
  Mazaheri Y, Afaq A, Rowe DB, Lu Y, Shukla-Dave A, Grover J Journal of computer assisted tomography 2012 36 695-703
- Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer
  Afaq A, Koh DM, Padhani A, Van As N, Sohaib SA BJU international 2011 Dec 108 1716-1722
- Imaging assessment of tumor response: Past, present and future
  Afaq A, Akin O Future Oncology 2011 May 7 669-677
- Diffusion-weighted MRI compared with pet in the detection of metastatic bone disease: A discussion of recent literature
  Afaq A, Sharma B Advances in Breast Cancer 2010 Sep 7 19-20
- Tracheomegaly: A complication of fetal endoscopic tracheal occlusion in the treatment of congenital diaphragmatic hernia
  McHugh K, Afaq A, Broderick N, Gabra HO, Roebuck DJ, Elliott MJ Pediatric radiology 2010 May 40 674-680
- Diffusion-weighted magnetic resonance imaging for tumour response assessment: Why, when and how?
  Afaq A, Andreou A, Koh DM Cancer Imaging 2010 10 S179-S188
- Improving undergraduate education in radiology
  Afaq A, McCall J Academic radiology 2002 9 221-223
- Filmless images for radiology teaching [10]
  Afaq A Journal of the Royal Society of Medicine 2001 94 554-555

New Patient Appointment or 214-645-9729